Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (311-320 of 395) with videos related to

Pageof 40
Sort By:
Annals of the Rheumatic Diseases|May 29, 2023
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indicationsMark D Russell, Christopher Stovin, Edward Alveyn, et al.
Rheumatology (Oxford, England)|April 15, 2021
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in ItalyStefania Spila Alegiani, Salvatore Crisafulli, Paolo Giorgi Rossi, et al.
Arthritis Care & Research|June 26, 2012
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicineElisa Gremese, Antonio Carletto, Melissa Padovan, et al.
Joint Bone Spine|September 13, 2017
Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugsFabiola Atzeni, Antonio Carletto, Rosario Foti, et al.
Clinical and Experimental Rheumatology|January 5, 2026
Coexistence of sarcoidosis and spondyloarthritis: a rare but intriguing associationAlessia Alunno, Francesco Carubbi, Begoña De Escalante, et al.
Arthritis Research & Therapy|June 24, 2020
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patientsPiero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.
Medicine|October 20, 2017
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studyPiero Ruscitti, Domenico Paolo Emanuele Margiotta, Federica Macaluso, et al.
Seminars in Arthritis and Rheumatism|December 24, 2025
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational "EMERGE" studyAndreina Manfredi, Caterina Vacchi, Stefania Cerri, et al.
Internal and Emergency Medicine|June 12, 2020
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)Caterina Vacchi, Marcella Visentini, Laura Gragnani, et al.
Clinical Rheumatology|April 26, 2019
Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot studyGiovanni Damiani, Paolo Daniele Maria Pigatto, Angelo Valerio Marzano, et al.
Pageof 40

Showing results (311-320 of 395) with videos related to

Sort By:
Pageof 40
Annals of the Rheumatic Diseases|May 29, 2023
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indicationsMark D Russell, Christopher Stovin, Edward Alveyn, et al.
Rheumatology (Oxford, England)|April 15, 2021
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in ItalyStefania Spila Alegiani, Salvatore Crisafulli, Paolo Giorgi Rossi, et al.
Arthritis Care & Research|June 26, 2012
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicineElisa Gremese, Antonio Carletto, Melissa Padovan, et al.
Joint Bone Spine|September 13, 2017
Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugsFabiola Atzeni, Antonio Carletto, Rosario Foti, et al.
Clinical and Experimental Rheumatology|January 5, 2026
Coexistence of sarcoidosis and spondyloarthritis: a rare but intriguing associationAlessia Alunno, Francesco Carubbi, Begoña De Escalante, et al.
Arthritis Research & Therapy|June 24, 2020
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patientsPiero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.
Medicine|October 20, 2017
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) studyPiero Ruscitti, Domenico Paolo Emanuele Margiotta, Federica Macaluso, et al.
Seminars in Arthritis and Rheumatism|December 24, 2025
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational "EMERGE" studyAndreina Manfredi, Caterina Vacchi, Stefania Cerri, et al.
Internal and Emergency Medicine|June 12, 2020
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)Caterina Vacchi, Marcella Visentini, Laura Gragnani, et al.
Clinical Rheumatology|April 26, 2019
Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot studyGiovanni Damiani, Paolo Daniele Maria Pigatto, Angelo Valerio Marzano, et al.
Pageof 40